Publications found:
58,333
Sort by:
Polyarticular Juvenile Idiopathic Arthritis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS PIPELINE REPORT INCLUDES Panorama of Polyarticular Juvenile Idiopathic Arthritis pipeline markets including statistics on therapeutic drugs and companies involved Polyarticular Juvenile Idiopathic Arthritis Pipeline candidates across ...
August 2018
60 pages
Polycystic Kidney Disease R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF POLYCYSTIC KIDNEY DISEASE PIPELINE REPORT INCLUDES Panorama of Polycystic Kidney Disease pipeline markets including statistics on therapeutic drugs and companies involved Polycystic Kidney Disease Pipeline candidates across various development ...
August 2018
90 pages
Polycystic Ovarian Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF POLYCYSTIC OVARIAN SYNDROME PIPELINE REPORT INCLUDES Panorama of Polycystic Ovarian Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Polycystic Ovarian Syndrome Pipeline candidates across various development ...
August 2018
40 pages
Polycythemia Vera R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF POLYCYTHEMIA VERA PIPELINE REPORT INCLUDES Panorama of Polycythemia Vera pipeline markets including statistics on therapeutic drugs and companies involved Polycythemia Vera Pipeline candidates across various development ...
August 2018
70 pages
Pompe Disease R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF POMPE DISEASE PIPELINE REPORT INCLUDES Panorama of Pompe Disease pipeline markets including statistics on therapeutic drugs and companies involved Pompe Disease Pipeline candidates across various development ...
August 2018
60 pages
Pontine Glioma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PONTINE GLIOMA PIPELINE REPORT INCLUDES Panorama of Pontine Glioma pipeline markets including statistics on therapeutic drugs and companies involved Pontine Glioma Pipeline candidates across various development ...
August 2018
210 pages
Portal Hypertension R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PORTAL HYPERTENSION PIPELINE REPORT INCLUDES Panorama of Portal Hypertension pipeline markets including statistics on therapeutic drugs and companies involved Portal Hypertension Pipeline candidates across various development ...
August 2018
60 pages
Post Menopausal Osteoporosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF POST MENOPAUSAL OSTEOPOROSIS PIPELINE REPORT INCLUDES Panorama of Post Menopausal Osteoporosis pipeline markets including statistics on therapeutic drugs and companies involved Post Menopausal Osteoporosis Pipeline candidates across various development ...
August 2018
70 pages
Post Polycythemia Vera Myelofibrosis (PPV MF) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF POST POLYCYTHEMIA VERA MYELOFIBROSIS (PPV MF) PIPELINE REPORT INCLUDES Panorama of Post Polycythemia Vera Myelofibrosis (PPV MF) pipeline markets including statistics on therapeutic drugs and companies involved Post Polycythemia Vera Myelofibrosis (PPV MF) Pipeline candidates across ...
August 2018
180 pages
Post Traumatic Stress Disorder R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF POST TRAUMATIC STRESS DISORDER PIPELINE REPORT INCLUDES Panorama of Post Traumatic Stress Disorder pipeline markets including statistics on therapeutic drugs and companies involved Post Traumatic Stress Disorder Pipeline candidates across ...
August 2018
100 pages
Postherpetic Neuralgia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF POSTHERPETIC NEURALGIA PIPELINE REPORT INCLUDES Panorama of Postherpetic Neuralgia pipeline markets including statistics on therapeutic drugs and companies involved Postherpetic Neuralgia Pipeline candidates across various development ...
August 2018
80 pages
Poxviridae Infections R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF POXVIRIDAE INFECTIONS PIPELINE REPORT INCLUDES Panorama of Poxviridae Infections pipeline markets including statistics on therapeutic drugs and companies involved Poxviridae Infections Pipeline candidates across various development ...
August 2018
80 pages
Prader Willi Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PRADER WILLI SYNDROME PIPELINE REPORT INCLUDES Panorama of Prader Willi Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Prader Willi Syndrome Pipeline candidates across various development ...
August 2018
70 pages
Pre Eclampsia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PRE ECLAMPSIA PIPELINE REPORT INCLUDES Panorama of Pre Eclampsia pipeline markets including statistics on therapeutic drugs and companies involved Pre Eclampsia Pipeline candidates across various development ...
August 2018
50 pages
Premature Ejaculation R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PREMATURE EJACULATION PIPELINE REPORT INCLUDES Panorama of Premature Ejaculation pipeline markets including statistics on therapeutic drugs and companies involved Premature Ejaculation Pipeline candidates across various development ...
August 2018
40 pages
Premature Labor (Tocolysis) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PREMATURE LABOR (TOCOLYSIS) PIPELINE REPORT INCLUDES Panorama of Premature Labor (Tocolysis) pipeline markets including statistics on therapeutic drugs and companies involved Premature Labor (Tocolysis) Pipeline candidates across various development ...
August 2018
40 pages
Premenstrual Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PREMENSTRUAL SYNDROME PIPELINE REPORT INCLUDES Panorama of Premenstrual Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Premenstrual Syndrome Pipeline candidates across various development ...
August 2018
30 pages
Presbyopia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF PRESBYOPIA PIPELINE REPORT INCLUDES Panorama of Presbyopia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Pressure Ulcers R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PRESSURE ULCERS PIPELINE REPORT INCLUDES Panorama of Pressure Ulcers pipeline markets including statistics on therapeutic drugs and companies involved Pressure Ulcers Pipeline candidates across various development ...
August 2018
30 pages
Primary Biliary Cirrhosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PRIMARY BILIARY CIRRHOSIS PIPELINE REPORT INCLUDES Panorama of Primary Biliary Cirrhosis pipeline markets including statistics on therapeutic drugs and companies involved Primary Biliary Cirrhosis Pipeline candidates across various development ...
August 2018
90 pages
Primary Hyperoxaluria R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PRIMARY HYPEROXALURIA PIPELINE REPORT INCLUDES Panorama of Primary Hyperoxaluria pipeline markets including statistics on therapeutic drugs and companies involved Primary Hyperoxaluria Pipeline candidates across various development ...
August 2018
40 pages
Primary Immune Deficiency R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PRIMARY IMMUNE DEFICIENCY PIPELINE REPORT INCLUDES Panorama of Primary Immune Deficiency pipeline markets including statistics on therapeutic drugs and companies involved Primary Immune Deficiency Pipeline candidates across various development ...
August 2018
70 pages
Primary Progressive Multiple Sclerosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS PIPELINE REPORT INCLUDES Panorama of Primary Progressive Multiple Sclerosis pipeline markets including statistics on therapeutic drugs and companies involved Primary Progressive Multiple Sclerosis Pipeline candidates across ...
August 2018
80 pages
Primary Sclerosing Cholangitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PRIMARY SCLEROSING CHOLANGITIS PIPELINE REPORT INCLUDES Panorama of Primary Sclerosing Cholangitis pipeline markets including statistics on therapeutic drugs and companies involved Primary Sclerosing Cholangitis Pipeline candidates across various development ...
August 2018
80 pages
Progressive Multifocal Leukoencephalopathy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY PIPELINE REPORT INCLUDES Panorama of Progressive Multifocal Leukoencephalopathy pipeline markets including statistics on therapeutic drugs and companies involved Progressive Multifocal Leukoencephalopathy Pipeline candidates across various ...
August 2018
20 pages
Progressive Relapsing Multiple Sclerosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF PROGRESSIVE RELAPSING MULTIPLE SCLEROSIS PIPELINE REPORT INCLUDES Panorama of Progressive Relapsing Multiple Sclerosis pipeline markets including statistics on therapeutic drugs and companies involved Progressive Relapsing Multiple Sclerosis Pipeline candidates across ...
August 2018
30 pages
Progressive Supranuclear Palsy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PROGRESSIVE SUPRANUCLEAR PALSY PIPELINE REPORT INCLUDES Panorama of Progressive Supranuclear Palsy pipeline markets including statistics on therapeutic drugs and companies involved Progressive Supranuclear Palsy Pipeline candidates across various development ...
August 2018
60 pages
Proliferative Diabetic Retinopathy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PROLIFERATIVE DIABETIC RETINOPATHY PIPELINE REPORT INCLUDES Panorama of Proliferative Diabetic Retinopathy pipeline markets including statistics on therapeutic drugs and companies involved Proliferative Diabetic Retinopathy Pipeline candidates across various development ...
August 2018
40 pages
Proliferative Vitreoretinopathy (PVR) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PROLIFERATIVE VITREORETINOPATHY (PVR) PIPELINE REPORT INCLUDES Panorama of Proliferative Vitreoretinopathy (PVR) pipeline markets including statistics on therapeutic drugs and companies involved Proliferative Vitreoretinopathy (PVR) Pipeline candidates across various development ...
August 2018
30 pages
Prosthetic joint infections R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PROSTHETIC JOINT INFECTIONS PIPELINE REPORT INCLUDES Panorama of Prosthetic joint infections pipeline markets including statistics on therapeutic drugs and companies involved Prosthetic joint infections Pipeline candidates across various development ...
August 2018
40 pages
Pruritus R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF PRURITUS PIPELINE REPORT INCLUDES Panorama of Pruritus pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
110 pages
Pseudomonas aeruginosa Pneumonia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PSEUDOMONAS AERUGINOSA PNEUMONIA PIPELINE REPORT INCLUDES Panorama of Pseudomonas aeruginosa Pneumonia pipeline markets including statistics on therapeutic drugs and companies involved Pseudomonas aeruginosa Pneumonia Pipeline candidates across various development ...
August 2018
30 pages
Psoriatic Arthritis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PSORIATIC ARTHRITIS PIPELINE REPORT INCLUDES Panorama of Psoriatic Arthritis pipeline markets including statistics on therapeutic drugs and companies involved Psoriatic Arthritis Pipeline candidates across various development ...
August 2018
190 pages
Psychosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF PSYCHOSIS PIPELINE REPORT INCLUDES Panorama of Psychosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Pulmonary Embolism R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF PULMONARY EMBOLISM PIPELINE REPORT INCLUDES Panorama of Pulmonary Embolism pipeline markets including statistics on therapeutic drugs and companies involved Pulmonary Embolism Pipeline candidates across various development ...
August 2018
30 pages
Pyelonephritis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF PYELONEPHRITIS PIPELINE REPORT INCLUDES Panorama of Pyelonephritis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
80 pages
Q Fever R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... VPA Research with comprehensive information of Q Fever pipeline products. The Q Fever pipeline guide presents complete overview of drugs currently ... and ready to use format. SCOPE OF Q FEVER PIPELINE REPORT INCLUDES Panorama of Q Fever pipeline markets including statistics on therapeutic drugs and companies ...
August 2018
30 pages
Rabies R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF RABIES PIPELINE REPORT INCLUDES Panorama of Rabies pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Radiation Injury R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF RADIATION INJURY PIPELINE REPORT INCLUDES Panorama of Radiation Injury pipeline markets including statistics on therapeutic drugs and companies involved Radiation Injury Pipeline candidates across various development ...
August 2018
40 pages
Radiodermatitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF RADIODERMATITIS PIPELINE REPORT INCLUDES Panorama of Radiodermatitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Ragweed Allergy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF RAGWEED ALLERGY PIPELINE REPORT INCLUDES Panorama of Ragweed Allergy pipeline markets including statistics on therapeutic drugs and companies involved Ragweed Allergy Pipeline candidates across various development ...
August 2018
30 pages
Ragweed Pollen Allergy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF RAGWEED POLLEN ALLERGY PIPELINE REPORT INCLUDES Panorama of Ragweed Pollen Allergy pipeline markets including statistics on therapeutic drugs and companies involved Ragweed Pollen Allergy Pipeline candidates across various development ...
August 2018
30 pages
Raynauds Disease R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF RAYNAUDS DISEASE PIPELINE REPORT INCLUDES Panorama of Raynauds Disease pipeline markets including statistics on therapeutic drugs and companies involved Raynauds Disease Pipeline candidates across various development ...
August 2018
40 pages
Rectal Cancer R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF RECTAL CANCER PIPELINE REPORT INCLUDES Panorama of Rectal Cancer pipeline markets including statistics on therapeutic drugs and companies involved Rectal Cancer Pipeline candidates across various development ...
August 2018
90 pages
Recurrent Malignant Glioma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF RECURRENT MALIGNANT GLIOMA PIPELINE REPORT INCLUDES Panorama of Recurrent Malignant Glioma pipeline markets including statistics on therapeutic drugs and companies involved Recurrent Malignant Glioma Pipeline candidates across various development ...
August 2018
40 pages
Reflux Esophagitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF REFLUX ESOPHAGITIS PIPELINE REPORT INCLUDES Panorama of Reflux Esophagitis pipeline markets including statistics on therapeutic drugs and companies involved Reflux Esophagitis Pipeline candidates across various development ...
August 2018
60 pages
Refractory Chronic Lymphocytic Leukemia (CLL) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PIPELINE REPORT INCLUDES Panorama of Refractory Chronic Lymphocytic Leukemia (CLL) pipeline markets including statistics on therapeutic drugs and companies involved Refractory Chronic Lymphocytic Leukemia (CLL) Pipeline candidates across ...
August 2018
210 pages
Relapsed Chronic Lymphocytic Leukemia (CLL) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PIPELINE REPORT INCLUDES Panorama of Relapsed Chronic Lymphocytic Leukemia (CLL) pipeline markets including statistics on therapeutic drugs and companies involved Relapsed Chronic Lymphocytic Leukemia (CLL) Pipeline candidates across ...
August 2018
240 pages
Relapsing Remitting Multiple Sclerosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF RELAPSING REMITTING MULTIPLE SCLEROSIS PIPELINE REPORT INCLUDES Panorama of Relapsing Remitting Multiple Sclerosis pipeline markets including statistics on therapeutic drugs and companies involved Relapsing Remitting Multiple Sclerosis Pipeline candidates across ...
August 2018
150 pages
